Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...
Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...
In an industry-first convergence of quantum photonics and precision medicine, INmune Bio Inc. (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) have entered into a commercial collaboration to ...
Explore KO/KD-validated antibodies that provide researchers with experimental evidence to assess antibody specificity ...
12h
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
("LarmorBio") today announced that Velocity Bioworks, Valion's wholly owned biologics contract development and manufacturing ...
INmune Bio and Quantum Computing Inc. partner to explore how AI and quantum computing can advance Alzheimer's drug research.
Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment ...
The project covers a secure knowledge vault, AI agents and access controls; delivery is scheduled by Dec. 15, subject to Bio ...
BIO-key International's MFA and SSO platform selected by a Middle East government agency to enhance identity security.
MitoCareX expands its internal bioinformatics expertise to broaden the analysis of disease biology within its computational drug-discovery ...
The AI Disruptors 60 is an annual list of the world's most groundbreaking AI startups, curated by Greenfield Partners. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results